Patents by Inventor Shaun Hunter

Shaun Hunter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11661627
    Abstract: An example method includes reacting a first solution and a different, second solution on a flow cell by flowing the first solution over amplification sites on the flow cell and subsequently flowing the second solution over the amplification sites. The first solution includes target nucleic acids and a first reagent mixture that comprises nucleoside triphosphates and replication enzymes. The target nucleic acids in the first solution transport to and bind to the amplification sites at a transport rate. The first reagent mixture amplifies the target nucleic acids that are bound to the amplification sites to produce clonal populations of amplicons originating from corresponding target nucleic acids. The amplicons are produced at an amplification rate that exceeds the transport rate. The second solution includes a second reagent mixture and lacks the target nucleic acids. The second solution is to increase a number of the amplicons at the amplification sites.
    Type: Grant
    Filed: September 25, 2020
    Date of Patent: May 30, 2023
    Assignees: Illumina, Inc., Illumina Cambridge Limited
    Inventors: Shaun Hunter, Peter McInerney, Jonathan Boutell, Claire Bevis-Mott
  • Publication number: 20220145384
    Abstract: A method of detecting materials in a mixture of materials may include providing materials, and providing oligonucleotides having different sequences than one another. Each of the oligonucleotides may be within, and may correspond to, a respective one of the materials. A mixture of at least two of the materials with one another may be obtained. The mixture may include the oligonucleotides corresponding to those materials. The method may include sequencing the oligonucleotides in the mixture; and detecting the materials corresponding to those oligonucleotides using the sequences of those oligonucleotides.
    Type: Application
    Filed: October 26, 2021
    Publication date: May 12, 2022
    Applicant: ILLUMINA, INC.
    Inventor: Shaun Hunter
  • Publication number: 20210010071
    Abstract: An example method includes reacting a first solution and a different, second solution on a flow cell by flowing the first solution over amplification sites on the flow cell and subsequently flowing the second solution over the amplification sites. The first solution includes target nucleic acids and a first reagent mixture that comprises nucleoside triphosphates and replication enzymes. The target nucleic acids in the first solution transport to and bind to the amplification sites at a transport rate. The first reagent mixture amplifies the target nucleic acids that are bound to the amplification sites to produce clonal populations of amplicons originating from corresponding target nucleic acids. The amplicons are produced at an amplification rate that exceeds the transport rate. The second solution includes a second reagent mixture and lacks the target nucleic acids. The second solution is to increase a number of the amplicons at the amplification sites.
    Type: Application
    Filed: September 25, 2020
    Publication date: January 14, 2021
    Inventors: Shaun Hunter, Peter McInerney, Jonathan Boutell, Claire Bevis-Mott
  • Patent number: 10808277
    Abstract: An example method includes reacting a first solution and a different, second solution on a flow cell by flowing the first solution over amplification sites on the flow cell and subsequently flowing the second solution over the amplification sites. The first solution includes target nucleic acids and a first reagent mixture that comprises nucleoside triphosphates and replication enzymes. The target nucleic acids in the first solution transport to and bind to the amplification sites at a transport rate. The first reagent mixture amplifies the target nucleic acids that are bound to the amplification sites to produce clonal populations of amplicons originating from corresponding target nucleic acids. The amplicons are produced at an amplification rate that exceeds the transport rate. The second solution includes a second reagent mixture and lacks the target nucleic acids. The second solution is to increase a number of the amplicons at the amplification sites.
    Type: Grant
    Filed: December 15, 2017
    Date of Patent: October 20, 2020
    Assignees: ILLUMINA, INC., ILLUMINA CAMBRIDGE LIMITED
    Inventors: Shaun Hunter, Peter McInerney, Jonathan Boutell, Claire Bevis-Mott
  • Publication number: 20180187252
    Abstract: An example method includes reacting a first solution and a different, second solution on a flow cell by flowing the first solution over amplification sites on the flow cell and subsequently flowing the second solution over the amplification sites. The first solution includes target nucleic acids and a first reagent mixture that comprises nucleoside triphosphates and replication enzymes. The target nucleic acids in the first solution transport to and bind to the amplification sites at a transport rate. The first reagent mixture amplifies the target nucleic acids that are bound to the amplification sites to produce clonal populations of amplicons originating from corresponding target nucleic acids. The amplicons are produced at an amplification rate that exceeds the transport rate. The second solution includes a second reagent mixture and lacks the target nucleic acids. The second solution is to increase a number of the amplicons at the amplification sites.
    Type: Application
    Filed: December 15, 2017
    Publication date: July 5, 2018
    Inventors: Shaun Hunter, Peter McInerney, Jonathan Boutell, Claire Bevis-Mott
  • Patent number: 9220739
    Abstract: An all-natural, multi-purpose body powder comprised of Boric Acid, Organic Lavender, Tea Tree, Eucalyptus and Peppermint. The ratios of Boric Acid to Organic Lavender and Tea Tree are 288:1. The ratios of Boric Acid to Organic Eucalyptus and Peppermint are 1728:1. All of said ingredients create an environment that bacteria cannot grow in, wherein body, foot and shoe odor is prevented.
    Type: Grant
    Filed: November 5, 2013
    Date of Patent: December 29, 2015
    Inventor: Shaun Hunter